Tango Therapeutics (TNGX) Equity Ratio: 2020-2025
Historic Equity Ratio for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to 0.76.
- Tango Therapeutics' Equity Ratio rose 17.11% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 17.11%. This contributed to the annual value of 0.63 for FY2024, which is 0.27% up from last year.
- Tango Therapeutics' Equity Ratio amounted to 0.76 in Q3 2025, which was up 34.24% from 0.57 recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Equity Ratio registered a high of 0.76 during Q3 2025, and its lowest value of 0.03 during Q1 2021.
- Its 3-year average for Equity Ratio is 0.63, with a median of 0.63 in 2024.
- In the last 5 years, Tango Therapeutics' Equity Ratio spiked by 2,221.27% in 2021 and then fell by 17.16% in 2023.
- Tango Therapeutics' Equity Ratio (Quarterly) stood at 0.69 in 2021, then fell by 17.08% to 0.57 in 2022, then grew by 10.00% to 0.63 in 2023, then climbed by 0.27% to 0.63 in 2024, then increased by 17.11% to 0.76 in 2025.
- Its last three reported values are 0.76 in Q3 2025, 0.57 for Q2 2025, and 0.61 during Q1 2025.